- Home
- BPMC vs SNDR Comparison
BPMC vs SNDR Comparison
Compare BPMC & SNDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- SNDR
- Stock Information
- Founded
- BPMC 2008
- SNDR 1935
- Country
- BPMC United States
- SNDR United States
- Employees
- BPMC N/A
- SNDR N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- SNDR Trucking Freight/Courier Services
- Sector
- BPMC Health Care
- SNDR Industrials
- Exchange
- BPMC Nasdaq
- SNDR Nasdaq
- Market Cap
- BPMC 5.8B
- SNDR 4.8B
- IPO Year
- BPMC 2015
- SNDR 2017
- Fundamental
- Price
- BPMC $97.17
- SNDR $22.86
- Analyst Decision
- BPMC Buy
- SNDR Buy
- Analyst Count
- BPMC 21
- SNDR 14
- Target Price
- BPMC $124.05
- SNDR $26.54
- AVG Volume (30 Days)
- BPMC 973.2K
- SNDR 740.1K
- Earning Date
- BPMC 05-01-2025
- SNDR 05-01-2025
- Dividend Yield
- BPMC N/A
- SNDR 1.66%
- EPS Growth
- BPMC N/A
- SNDR N/A
- EPS
- BPMC N/A
- SNDR 0.71
- Revenue
- BPMC $562,121,000.00
- SNDR $5,373,300,000.00
- Revenue This Year
- BPMC $44.85
- SNDR $12.31
- Revenue Next Year
- BPMC $32.06
- SNDR $6.50
- P/E Ratio
- BPMC N/A
- SNDR $32.43
- Revenue Growth
- BPMC 99.19
- SNDR N/A
- 52 Week Low
- BPMC $73.04
- SNDR $20.59
- 52 Week High
- BPMC $121.90
- SNDR $33.90
- Technical
- Relative Strength Index (RSI)
- BPMC 59.54
- SNDR 54.52
- Support Level
- BPMC $87.03
- SNDR $22.13
- Resistance Level
- BPMC $104.86
- SNDR $23.13
- Average True Range (ATR)
- BPMC 3.86
- SNDR 0.75
- MACD
- BPMC 1.24
- SNDR 0.20
- Stochastic Oscillator
- BPMC 64.38
- SNDR 92.31
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About SNDR Schneider National Inc.
Schneider National Inc is a provider of surface transportation and logistics solutions in North America. The Company offers truckload, intermodal, and logistics services to a diverse customer base throughout the continental United States, Canada, and Mexico. The company's segments include Truckload; Intermodal; Logistics and other. It generates maximum revenue from the Truckload segment.